These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 28744656

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients.
    Wada I, Oshima Y, Shiose S, Kano K, Nakao S, Kaizu Y, Yoshida S, Ishibashi T, Sonoda KH.
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1411-1418. PubMed ID: 31119425
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting.
    Vardarinos A, Gupta N, Janjua R, Iron A, Empeslidis T, Tsaousis KT.
    BMC Ophthalmol; 2017 Apr 27; 17(1):58. PubMed ID: 28449645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study.
    Silva R, Berta A, Larsen M, Macfadden W, Feller C, Monés J, TREND Study Group.
    Ophthalmology; 2018 Jan 27; 125(1):57-65. PubMed ID: 28893454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Investigation of genetic base in the treatment of age-related macular degeneration.
    Gourgouli K, Gourgouli I, Tsaousis G, Spai S, Niskopoulou M, Efthimiopoulos S, Lamnissou K.
    Int Ophthalmol; 2020 Apr 27; 40(4):985-997. PubMed ID: 31916060
    [Abstract] [Full Text] [Related]

  • 13. Gas-mediated vitreomacular adhesion release with intravitral ranibizumab injections for exudative age-related macular degeneration.
    Kang HM, Lee SJ, Kim CG, Chung EJ, Koh HJ.
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep 27; 254(9):1681-92. PubMed ID: 26743753
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocol.
    Jørstad ØK, Faber RT, Moe MC.
    Acta Ophthalmol; 2017 Aug 27; 95(5):460-463. PubMed ID: 28556485
    [Abstract] [Full Text] [Related]

  • 16. Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Hata M, Tsujikawa A, Miyake M, Yamashiro K, Ooto S, Oishi A, Nakanishi H, Takahashi A, Yoshimura N.
    Graefes Arch Clin Exp Ophthalmol; 2015 Feb 27; 253(2):221-7. PubMed ID: 24961698
    [Abstract] [Full Text] [Related]

  • 17. Assessment of Choroidal Topographic Changes by Swept-Source Optical Coherence Tomography After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.
    Razavi S, Souied EH, Darvizeh F, Querques G.
    Am J Ophthalmol; 2015 Nov 27; 160(5):1006-13. PubMed ID: 26275471
    [Abstract] [Full Text] [Related]

  • 18. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Abedi F, Wickremasinghe S, Richardson AJ, Islam AF, Guymer RH, Baird PN.
    Ophthalmology; 2013 Aug 27; 120(8):1641-8. PubMed ID: 23582991
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.